YatırımMasasıYatırım Masası home
Mary Miller, Acrivon Therapeutics stock sale
Chief legal officer, SEC Form 4, filed on August 20, 2026
$372185 shares, average $2.01
- Transaction date
- August 18, 2026
- Shares held after
- 82,009Direct ownership
- Change in holding
- −0.23%From the transactions in the filing
- Filing rows
- 1All open market
Price context
ACRV daily close, Apr 20 to October 26, 2026$2.39$1.38
Daily close
Sale
Trade average $2.01
- Transaction price
- $2.01Weighted average
- Close on trade date
- $2.05August 18, 2026
- Latest close
- $1.72October 26, 2026
- Since the trade
- −14.43%vs the trade average
Transactions in the filing
DateTransactionSecuritySharesPriceAmountAfter
Sale
Common stockDirect
185
$2.01
$372
82,009
Recent filings at Acrivon Therapeutics
Full historyPersonTransactionAmount or sharesDate